Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

The goal of this observational study is to use digital health tracking to improve how high blood pressure and other health issues are detected in pregnant refugee women. The main questions this study aims to answer are are: * Can a digital monitoring system that checks for high blood pressure in these women be tested and refined, using clinical training and validation? * Can this digital monitoring system accurately track any related pregnancy health issues and be used to refer participants to care providers? * Can this system be used to accurately identify risks associated with the contraction of pregnancy-related conditions, such as preeclampsia and high blood pressure? Participants will: * Complete baseline and follow-up in-person appointments; * Complete surveys at these appointment that track their health, stress levels, and comorbidities/risks associated with pregnancy; * Be given a smartwatch fitness tracker and electronic blood pressure cuffs for at-home measurements.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: t
View:

• Pregnant

• Refugee, asylum seeking, or asylee as designated by the U.S. Government

• Greater than or equal to 18 years of age

• Has a personal smartphone

Locations
United States
New York
Weill Cornell Medicine
RECRUITING
New York
Contact Information
Primary
Gunisha Kaur, MA, MD
gus2004@med.cornell.edu
(212) 746-2461
Backup
Michele Steinkamp, RN
mls9004@med.cornell.edu
2127462953
Time Frame
Start Date: 2024-09-12
Estimated Completion Date: 2026-09
Participants
Target number of participants: 75
Treatments
Pregnant Refugees
Participants will complete validated questionnaires, regular blood pressure measurements, pain and trauma assessments, and clinical monitoring during this study.
Related Therapeutic Areas
Sponsors
Leads: Weill Medical College of Cornell University
Collaborators: National Academy of Medicine, Cornell University, Apple Inc.

This content was sourced from clinicaltrials.gov